Steve Yang, Ph.D.
Co-CEO
A pharmaceutical industry leader recognized for building R&D and service capabilities, delivering research and early development portfolios of drug candidates, and establishing R&D partnerships in US, Europe, China and other Asian and emerging markets. Before joining WuXi AppTec, Dr. Yang was Vice President and Head of Asia and Emerging Markets IMED at AstraZeneca, and served as Vice President and Head of Asia R&D at Pfizer and as Executive Director and head of Pfizer's global R&D strategic management group. Dr. Yang received his Ph.D. in pharmaceutical chemistry from the University of California, San Francisco.
Letian Kuai, Ph.D.
Vice President, Head of WuXi Biology, Head of Discovery Biology Unit (DBU), Head of WuXi Biology HitS
Letian Kuai received his Ph.D. in biochemistry from the University of Rochester in 2004, followed by post-doctoral training at the Broad Institute of MIT and Harvard. At a leading pharmaceutical company, he became a key innovator and contributor to the development of DNA-Encoded Library (DEL) technology. Dr. Kuai joined WuXi AppTec HitS in 2018, and built an integrated suite of high-quality and customizable solutions, with capabilities spanning protein and antibody sciences, DNA-encoded libraries, biophysics, and structural biology.
